Strategies for the treatment of myasthenia gravis.
Drachman
D B
DB
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
McIntosh
K R
KR
De Silva
S
S
Kuncl
R W
RW
Kahn
C
C
D001402:B-Lymphocytes / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000503:physiopathology / Q000628:therapy*; D009469:Neuromuscular Junction / Q000503:physiopathology; D011978:Receptors, Nicotinic / Q000502:physiology; D009435:Synaptic Transmission; D013601:T-Lymphocytes / Q000276:immunology
D007130:Immunoglobulin Idiotypes; D007166:Immunosuppressive Agents; D011978:Receptors, Nicotinic